Arcaro A, Guerreiro AS (2007) The phosphoinositide 3-kinase pathway in human cancer: genetic alterations and therapeutic implications. Curr Genomics 8:271–306
PubMed
Article
CAS
Google Scholar
Berenjeno IM, Núñez F, Bustelo XR (2007) Transcriptomal profiling of the cellular transformation induced by Rho subfamily GTPases Oncogene. Oncogene 26:4295–4305
PubMed
Article
CAS
Google Scholar
Bolis A, Corbetta S, de Cioce ACI (2003) Differential distribution of Rac1 and Rac3 GTPases in the developing mouse brain: implications for a role of Rac3 in Purkinje cell differentiation. Eur J Neurosci 18:2417–2424
PubMed
Article
Google Scholar
Chan AY, Coniglio SJ, Chuang YY, Michaelson D, Knaus UG, Philips MR, Symons M (2005) Roles of the Rac1 and Rac3 GTPases in human tumor cell invasion. Oncogene 24:7821–7829
PubMed
Article
CAS
Google Scholar
David M, Wasif A, Daniele G, Mo Z, Ian A, Michele P, Mark RP (2008) Rac1 accumulates in the nucleus during the G2 phase of the cell cycle and promotes cell division. J Cell Biol 181:485–496
Article
Google Scholar
Friedl P, Wolf K (2010) Plasticity of cell migration: a multiscale tuning model. J Cell Biol 188:11–19
PubMed
Article
CAS
Google Scholar
Gilbertson RJ (2004) Medulloblastoma: signalling a change in treatment. Lancet Oncol 5:209–218
PubMed
Article
Google Scholar
Giovanni D, Giovanni V, Sara T, Loredana F, Massimo P, Cristina Z, Stefania M, Alessia F, Carla F (2007) Enhancement of learning and memory after activation of cerebral Rho GTPases. Proc Natl Acad Sci 104:636–641
Article
Google Scholar
Hwang SL, Chang JH, Cheng CY, Howng SL, Sy WD, Lieu AS, Lin CL, Lee KS, Hong YR (2005) The expression of rac1 pseudogene in human tissues and in human brain tumors. Eur Surg Res 37:100–104
PubMed
Article
CAS
Google Scholar
James M, Daniel Z, Chiharu H, Fabian OY, Shuh N, Naoki W (2009) Cdc42 and Rac family GTPases regulate mode and speed but not direction of primary fibroblast migration during platelet-derived growth factor-dependent chemotaxis. Mol Cell Biol 29:2730–2747
Article
Google Scholar
Jarzynka MJ, Hu B, Hui KM, Bar-Joseph I, Gu W, Hirose T, Haney LB, Ravichandran KS, Nishikawa R, Cheng SY (2007) ELMO1 and Dock180, a bipartite Rac1 guanine nucleotide exchange factor, promote human glioma cell invasion. Cancer Res 67:7203–7211
PubMed
Article
CAS
Google Scholar
Jennifer AA, Janet CL, Meryl EL, Richard JG, Simon B, David WE, Steven CC (2008) Global analysis of the medulloblastoma epigenome identifies disease-subgroup-specific inactivation of COL1A2. Neuro Oncol 10:981–994
Article
Google Scholar
Kunigal S, Gondi CS, Gujrati M, Lakka SS, Dinh DH, Olivero WC, Rao JS (2006) SPARC-induced migration of glioblastoma cell lines via uPA-uPAR signaling and activation of small GTPase RhoA. Int J Oncol 29:1349–1357
Google Scholar
Lämmermann T, Sixt M (2009) Mechanical modes of ‘amoeboid’ cell migration. Curr Opin Cell Biol 21:636–644
PubMed
Article
Google Scholar
Matthias M, Louis H, Christopher W, Hunter E, Olivier P, Perihan N, Amy A, Gary LJ, Klaus MH, Gaudenz D (2009) Coordination of Rho GTPase activities during cell protrusion. Nature 461:99–103
Article
Google Scholar
Mira JP, Benard V, Groffen J, Sanders LC, Knaus UG (2000) Endogenous, hyperactive Rac3 controls proliferation of breast cancer cells by a p21-activated kinase-dependent pathway. Proc Natl Acad Sci USA 97:185–189
PubMed
Article
CAS
Google Scholar
Raftopoulou M, Hall A (2004) Cell migration: Rho GTPases lead the way. Dev Biol 265:23–32
PubMed
Article
CAS
Google Scholar
Salhia B, Rutten F, Nakada M, Beaudry C, Berens M, Kwan A, Rutka T (2005) Inhibition of Rho-Kinase affects astrocytoma morphology, motility, and invasion through activation of Rac1. Cancer Res 65:8792–8800
PubMed
Article
CAS
Google Scholar
Salhia B, Tran NL, Chan A, Wolf A, Nakada M, Rutka F, Ennis M, McDonough WS, Berens ME, Symons M, Rutka JT (2008) The guanine nucleotide exchange factors trio, Ect2, and Vav3 mediate the invasive behavior of glioblastoma. Am J Pathol 173:1828–1838
PubMed
Article
CAS
Google Scholar
Sanz-Moreno V, Gadea G, Ahn J, Paterson H, Marra P, Pinner S, Sahai E, Marshall CJ (2008) Rac activation and inactivation control plasticity of tumor cell movement. Cell 35:510–523
Article
Google Scholar
Shirsat NV, Pignolo RJ, Kreider BL, Rovera G (1990) A member of the ras gene superfamily is expressed specifically in T, B and myeloid hemopoietic cells. Oncogene 5:769–772
PubMed
CAS
Google Scholar
Small JV, Stradal TE, Vignal RK (2002) The lamellipodium: where motility begins. Trends Cell Biol 12:112–120
PubMed
Article
CAS
Google Scholar
Sugihara K, Nakatsuji N, Nakamura K, Nakao K, Hashimoto R, Otani H, Sakagami H, Kondo H, Nozawa S, Aiba A, Katsuki M (1998) Oncogene Rac1 is required for the formation of three germ layers during gastrulation. Oncogene 17:3427–3433
PubMed
Article
CAS
Google Scholar
Tran NL, McDonough WS, Savitch BA, Fortin SP, Winkles JA, Symons M, Nakada M, Cunliffe HE, Hostetter G, Hoelzinger DB, Rennert JL, Michaelson JS, Burkly LC, Lipinski CA, Loftus JC, Mariani L, Berens ME (2006) Increased fibroblast growth factor-inducible 14 expression levels promote glioma cell invasion via Rac1 and nuclear factor-kappaB and correlate with poor patient outcome. Cancer Res 66:9535–9542
PubMed
Article
CAS
Google Scholar
Vega FM, Ridley AJ (2008) Rho GTPases in cancer cell biology. FEBS Lett 582:2093–2101
PubMed
Article
CAS
Google Scholar
Wolf K, Mazo I, Leung H, Engelke K, von Andrian UH, Deryugina EI, Strongin AY, Bröcker EB, Friedl P (2003) Compensation mechanism in tumor cell migration: mesenchymal-amoeboid transition after blocking of pericellular proteolysis. J Cell Biol 160:267–277
PubMed
Article
CAS
Google Scholar
Wu YI, Frey D, Lungu OI, Jaehrig A, Schlichting I, Kuhlman B, Hahn KM (2009) A genetically encoded photoactivatable Rac controls the motility of living cells. Nature 461:104–108
PubMed
Article
CAS
Google Scholar
Xosé RB, Vincent S, Inmaculada MB (2007) GTP-binding proteins of the Rho/Rac family: regulation effectors and functions in vivo. Bioessays 29:356–370
Article
Google Scholar
Zhang B (2006) Rho GDP dissociation inhibitors as potential targets for anticancer treatment. Drug Resist Update 9:134–141
Article
CAS
Google Scholar